The company is targeting cash flow positive status in the second half of 2024.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals submits IND application to FDA for AUR200
- Aurinia Pharmaceuticals put volume heavy and directionally bearish
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia strength may be related to Gilead suspicion, says Gordon Haskett
- Aurinia Pharmaceuticals partner Otsuka files NDA in Japan for Lupkynis